Screening for Liver Steatosis and Fibrosis in Patients with Inflammatory Bowel Disease Using Vibration Controlled Transient Elastography with Controlled Attenuation Parameter

Screening for Liver Steatosis and Fibrosis in Patients with Inflammatory Bowel Disease Using Vibration Controlled Transient Elastography with Controlled Attenuation Parameter

Background and Aims: Inflammatory bowel diseases (IBD) are frequently associated with extraintestinal manifestations, hepatic injury being of concern in these patients. Current literature reports an increased prevalence of liver steatosis and fibrosis in subjects with IBD and the pathophysiology is...

Full description

Bibliographic Details
Main Authors:	Anca Trifan, Remus Stafie, Adrian Rotaru, Ermina Stratina, Sebastian Zenovia, Robert Nastasa, Laura Huiban, Tudor Cuciureanu, Cristina Muzica, Stefan Chiriac, Irina Girleanu, Ana-Maria Singeap, Catalin Sfarti, Camelia Cojocariu, Oana Petrea, Carol Stanciu
Format:	Article
Language:	English
Published:	MDPI AG 2022-10-01
Series:	Journal of Clinical Medicine
Subjects:	inflammatory bowel disease non-alcoholic fatty liver disease liver fibrosis vibration-controlled transient elastography
Online Access:	https://www.mdpi.com/2077-0383/11/19/5959

Similar Items

Simultaneously Screening for Liver Steatosis and Fibrosis in Romanian Type 2 Diabetes Mellitus Patients Using Vibration-Controlled Transient Elastography with Controlled Attenuation Parameter
by: Anca Trifan, et al.
Published: (2022-07-01)

Changes in Liver Steatosis Using Controlled Attenuation Parameter among Patients with Chronic Hepatitis C Infection Treated with Direct-Acting Antivirals Therapy Who Achieved Sustained Virological Response
by: Anca Trifan, et al.
Published: (2022-03-01)

The Prevalence of Liver Steatosis and Fibrosis Assessed by Vibration-Controlled Transient Elastography and Controlled Attenuation Parameter in Apparently Healthy Romanian Medical Students
by: Robert Nastasa, et al.
Published: (2021-12-01)

Clinical and Laboratory Characteristics of Normal Weight and Obese Individuals with Non-Alcoholic Fatty Liver Disease
by: Anca Trifan, et al.
Published: (2022-03-01)

Predictive Factors for the Prognosis of Alcoholic Liver Cirrhosis
by: Anca Trifan, et al.
Published: (2022-12-01)

The Role of Presepsin in Diagnosing Infections in Patients with Liver Cirrhosis and Overt Hepatic Encephalopathy
by: Razvan Igna, et al.
Published: (2022-08-01)

Anticoagulation for Atrial Fibrillation in Patients with Decompensated Liver Cirrhosis: Bold and Brave?
by: Irina Gîrleanu, et al.
Published: (2023-03-01)

The Role of Presepsin and Procalcitonin in Early Diagnosis of Bacterial Infections in Cirrhotic Patients with Acute-on-Chronic Liver Failure
by: Razvan Igna, et al.
Published: (2022-09-01)

Vibration-Controlled Transient Elastography and Controlled Attenuation Parameter for the Diagnosis of Liver Steatosis and Fibrosis in Patients with Nonalcoholic Fatty Liver Disease
by: Sebastian Zenovia, et al.
Published: (2021-04-01)

High prevalence of liver fibrosis among general population: a Romanian population-based study
by: Anca Trifan, et al.
Published: (2023-02-01)

Changes in Components of Metabolic Syndrome after Antiviral Eradication in Hepatitis C Virus Infection
by: Anca Trifan, et al.
Published: (2023-02-01)

The Impact of Alcohol Consumption Pattern on Liver Fibrosis in Asymptomatic Patients
by: Horia Minea, et al.
Published: (2023-11-01)

Impaired Intestinal Permeability Assessed by Confocal Laser Endomicroscopy—A New Potential Therapeutic Target in Inflammatory Bowel Disease
by: Stefan Chiriac, et al.
Published: (2023-03-01)

Ischemic Heart Disease and Liver Cirrhosis: Adding Insult to Injury
by: Irina Gîrleanu, et al.
Published: (2022-07-01)

The Risk of <i>Clostridioides difficile</i> Infection in Cirrhotic Patients Receiving Norfloxacin for Secondary Prophylaxis of Spontaneous Bacterial Peritonitis—A Real Life Cohort
by: Irina Girleanu, et al.
Published: (2021-09-01)

Hepatitis C Virus Prevalence and Risk Factors in a Village in Northeastern Romania—A Population-Based Screening—The First Step to Viral Micro-Elimination
by: Laura Huiban, et al.
Published: (2021-05-01)

Clinical Impact of Small Bowel Capsule Endoscopy in Obscure Gastrointestinal Bleeding
by: Ana-Maria Singeap, et al.
Published: (2020-10-01)

Systemic Oxidative Stress Markers in Cirrhotic Patients with Hepatic Encephalopathy: Possible Connections with Systemic Ammoniemia
by: Cătălin Sfarti, et al.
Published: (2020-04-01)

Idiopathic Cervical Esophageal Webs: A Case Report and Literature Review
by: Petrea OC, et al.
Published: (2020-11-01)

The Impact of the COVID-19 Pandemic on Gastrointestinal Endoscopy Activity in a Tertiary Care Center from Northeastern Romania
by: Stefan Chiriac, et al.
Published: (2021-01-01)

L3 Skeletal Muscle Index Dynamics in Patients with HCV-Related Compensated Cirrhosis Following Sustained Virological Response after Direct Acting Antiviral Treatment
by: Florin Mihai, et al.
Published: (2021-11-01)

Liver Remodeling on CT Examination in Patients with HCV Compensated Cirrhosis Who Achieved Sustained Virological Response after Direct-Acting Antivirals Treatment
by: Florin Mihai, et al.
Published: (2020-04-01)

Natural course of nonmalignant partial portal vein thrombosis in cirrhotic patients
by: Irina Girleanu, et al.
Published: (2014-01-01)

Reclassification of Inflammatory Bowel Disease Type Unclassified by Small Bowel Capsule Endoscopy
by: Ana-Maria Singeap, et al.
Published: (2023-11-01)

Transient elastography with controlled attenuation parameter versus two-dimensional shear wave elastography with attenuation imaging for the evaluation of hepatic steatosis and fibrosis in NAFLD
by: Jung Wook Seo, et al.
Published: (2023-07-01)

Small Bowel Capsule Endoscopy and Enteroscopy: A Shoulder-to-Shoulder Race
by: Ana-Maria Singeap, et al.
Published: (2023-11-01)

The Relation between Post-Endoscopic Retrograde Cholangiopancreatography Pancreatitis and Different Cannulation Techniques: The Experience of a High-Volume Center from North-Eastern Romania
by: Stefan Chiriac, et al.
Published: (2023-06-01)

Associations of Uric Acid With Liver Steatosis and Fibrosis Applying Vibration Controlled Transient Elastography in the United States: A Nationwide Cross-Section Study
by: Hualin Duan, et al.
Published: (2022-06-01)

Liver Involvement in Patients with Systemic Sclerosis: Role of Transient Elastography in the Assessment of Hepatic Fibrosis and Steatosis
by: Giovanna Cuomo, et al.
Published: (2023-05-01)

Dietary inflammatory index in relation to the progression of hepatic steatosis and liver fibrosis: evaluation by elastography/Fibroscan
by: Mahsa Miryan, et al.
Published: (2024-04-01)

The presence of diabetes impacts liver fibrosis and steatosis by transient elastography in a primary care population
by: Hirsh D. Trivedi, et al.
Published: (2021-09-01)

Clinical Relevance of Vitamins and Carotenoids With Liver Steatosis and Fibrosis Detected by Transient Elastography in Adults
by: Xiaohui Liu, et al.
Published: (2021-11-01)

The role of alginate-based therapy in gastroesophageal reflux disease
by: Ana-Maria SINGEAP, et al.
Published: (2020-09-01)

Quantitative ultrasound radiofrequency data analysis for the assessment of hepatic steatosis using the controlled attenuation parameter as a reference standard
by: Sun Kyung Jeon, et al.
Published: (2021-01-01)

Assessment of hepatic fibrosis and steatosis by vibration-controlled transient elastography and controlled attenuation parameter versus non-invasive assessment scores in patients with non-alcoholic fatty liver disease
by: Ahmed M. F. Mansour, et al.
Published: (2020-09-01)

Detectability of Liver Steatosis and Fibrosis with Transient Elastography and Controlled Attenuation Parameter in Residents of St. Petersburg
by: V. P. Kovyazina, et al.
Published: (2021-04-01)

Accuracy of attenuation imaging in the assessment of pediatric hepatic steatosis: correlation with the controlled attenuation parameter
by: Pyeong Hwa Kim, et al.
Published: (2022-10-01)

Transient Elastography and Controlled Attenuation Parameter (CAP) in the Assessment of Liver Steatosis in Severe Adult Growth Hormone Deficiency
by: Adriana Claudia Lopes Carvalho-Furtado, et al.
Published: (2019-06-01)

Association Between Subclinical Left Ventricular Myocardial Systolic Dysfunction Detected by Strain and Strain‑Rate Imaging and Liver Steatosis and Fibrosis Detected by Elastography and Controlled Attenuation Parameter in Patients with Metabolic Syndrome
by: Vitel A, et al.
Published: (2020-10-01)

The Prevalence of Liver Fibrosis Stages on More than 23,000 Liver Stiffness Measurements by Vibration-Controlled Transient Elastography: A Single Center Study
by: Alin Lazar, et al.
Published: (2023-08-01)